SCHEMBL18671857

SCHEMBL18671857

CC[C@H]1O[C@H](OC(=O)c2ccccc2)C(=O)[C@@H]1OC(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.43
▸ LGALS9 O00182 1/20 0.40
▸ LGALS1 P09382 1/20 0.40
▸ LGALS3 P17931 1/20 0.40
▸ LGALS7; LGALS7B P47929 1/20 0.40
▸ KMT2A Q03164 6/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ TRPM8 Q7Z2W7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561531 1.00 LMNA (0.43) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL14929037 1.00 LMNA (0.43) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL19866479 0.87 LGALS9 (0.49) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL14616525 0.86 LGALS9 (0.40) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL14853797 0.86 POLB (0.47) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL24522365 0.86 POLB (0.47) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL15071561 0.86 LGALS9 (0.40) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL16258710 0.86 POLB (0.47) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL21007945 0.86 POLB (0.47) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL15394247 0.86 LGALS9 (0.40) LMNALGALS9LGALS1LGALS3LGALS7; LGALS7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9605018-B2 Substituted nucleotide analogs ALIOS BIOPHARMA, INC. (US) 2017-03-28 — — US disclosed
Send feedback